Ga verder naar de inhoud

Second National CAR-T Symposium: International Speaker: Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell therapy: long term management of patients post CAR-T

Presenter: Prof. Elise Chong (University of Pennsylvania) - Oct 26, 2021

This recording encompasses the 4th session of the Second National CAR-T Symposium meeting that took place on Tuesday, October 26th, 2021 from 19.00 to 21.05 CET.

Scientific programme:

19h00
Introduction and opening remarks

19h10
CAR-T Cell Therapy. The Evidence in Belgium so Far
Dr. Sarah Bailly (Cliniques Universitaires Saint-Luc) and Dr. Sophie Servais (CHU Liège) (Please note that this recording is not available yet)

19h25
Practical Considerations for CAR-T Cell Therapy
Prof. Dr. Peter Vandenberghe (UZ Leuven) & Dr Ciel De Vriendt (UZ Gent)

19h45
Treatment of r/r ALL: New Insights
Prof. Barbara De Moerloose (UZ Gent)

19h55
International Speaker: Five-Year Outcomes for Refractory B-Cell Lymphomas with CAR T-Cell therapy: long term management of patients post CAR-T
Prof. Elise Chong (University of Pennsylvania)

20h15
Panel Discussion and Live Q&A: From Primary Hematologist to CAR-T Center and Back

21h00
Closing Remarks

Log in to see this content or if you don't have an account, please create one.